Evidence map›Paper›PMID 37570703›Full record

ArticleMolecules (Basel, Switzerland)2023

Novel Cytotoxic Sesquiterpene Coumarin Ethers and Sulfur-Containing Compounds from the Roots of

Fatma Memnune Eruçar, Sarath P D Senadeera, Jennifer A Wilson, Ekaterina Goncharova, John A Beutler, Mahmut Miski

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Sesquiterpenes and Sesquiterpene Derivatives fromAntioxidants (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fatma Memnune EruçarDepartment of Pharmacognosy, Faculty of Pharmacy, Istanbul University, Istanbul 34116, Türkiye.ORCID 0000-0003-4742-0371
Sarath P D SenadeeraMolecular Targets Program, National Institutes of Health, National Cancer Institute, Frederick, MD 21702, USA.
Jennifer A WilsonMolecular Targets Program, National Institutes of Health, National Cancer Institute, Frederick, MD 21702, USA.
Ekaterina GoncharovaMolecular Targets Program, National Institutes of Health, National Cancer Institute, Frederick, MD 21702, USA.
John A BeutlerMolecular Targets Program, National Institutes of Health, National Cancer Institute, Frederick, MD 21702, USA.ORCID 0000-0002-4646-1924
Mahmut MiskiDepartment of Pharmacognosy, Faculty of Pharmacy, Istanbul University, Istanbul 34116, Türkiye.

Funding

Building Libraries with Chemical Diversity for ScreeningZIABC011469 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI BEUTLER, JOHN · 2012 to 2025
$7.8M
Development of Natural Product Leads as Anticancer TherapeuticsZIABC011470 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI BEUTLER, JOHN · 2012 to 2025
$7.8M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIA BC011470NCI NIH HHS HHSN261200800001ENCI NIH HHS ZIABC011470-11, ZIABC011469-11
6 · The paper itself

Abstract

Six new sesquiterpene coumarin ethers, namely turcicanol A (

Indexed as

Anesthetics, GeneralAntineoplastic AgentsAntineoplastic Agents, PhytogenicFerulaSesquiterpenesCoumarinsEthersMolecular StructurePlant RootsSulfurSulfur CompoundsAnesthetics, GeneralAntineoplastic AgentsAntineoplastic Agents, PhytogenicCoumarinsEthersSesquiterpenesSulfurSulfur CompoundsApiaceaecolon cancercytotoxic activityFerula turcicakidney cancersesquiterpene coumarin etherssulfur-containing compounds

Identifiers

PMID37570703
PMCPMC10420993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.